Stockrabit · Analysts
Questions across 2 calls

Ashish Kabra

Firm not listed in source transcripts

Natco Pharma Limited

Piramal Pharma Limited

Piramal Pharma Limited CC-Sep24.pdf · 2024-10-24
Congratulations on a great set of numbers. I just want to -- just build on that, that you said that Q3 and Q4 are on a historical level, they are better than Q1 and Q2. But since this year's Q2, you said that the mix was different. Do you still think that Q3 and Q4 of this financial will be greater than Q1 and Q2?
Okay, sir. And sir, 1 thing the way Piramal Pharma is growing, the guidance that you gave for FY '30, can you -- do you feel that in subsequent years, we have to actually -- you have to relook at the guidance and that can be met before FY '30?